Updates on Aflibercept BPCIA Litigation - January 2023 | Goodwin

On January 10, 2024, Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed a Complaint in the U.S. District Court for the Central District of California against Amgen Inc. (“Amgen”)...

Related Keywords

California ,United States ,West Virginia , ,Amgen ,Regeneron Pharmaceuticals Inc ,Us District Court ,Amgen Inc ,Filed Complaint Against Amgen ,Regeneron Pharmaceuticals ,Central District ,Judicial Panel ,Multidistrict Litigation ,Northern District ,Chief Judge Kleeh ,Samsung Bioepis ,Big Molecule Watch ,